Celularity Regains Compliance With Nasdaq Reporting Requirement
Nasdaq closed Celularity’s reporting deficiency after the company filed its second-quarter 2026 Form 10-Q.
Nasdaq closed Celularity’s reporting deficiency after the company filed its second-quarter 2026 Form 10-Q.